Craig Metz


Dr. Metz leads all Regulatory affairs at Marius and has over 38 years of pharmaceutical industry experience. At GlaxoSmithKline, Dr. Metz served as Vice President of U.S. Regulatory Affairs and led the group responsible for providing strategic regulatory support to all early stage pharmaceutical development activities conducted by GSK’s Centers for Excellence in Drug Discovery. In this capacity, he was responsible for overseeing the development, coordination and execution of regulatory strategy across the complete clinical spectrum of GSK discovery research and was involved with regulatory interactions across all FDA Reviewing Divisions.

Additional Information